BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 15, 2011
View Archived Issues
TAK-075 is a new, stable, orally active bone anabolic agent for osteoporosis
Read More
Acetone level in exhaled breath as a new biomarker of heart failure
Read More
Merck & Co. describes new inhibitors of MAP/microtubule affinity-regulating kinase 3
Read More
Clinical phase I and II data presented on TMC-435 for hepatitis C
Read More
EMD-1204831 shows antitumor activity in preclinical studies
Read More
Cellmid reports preclinical data on midkine in acute myocardial infarction
Read More
Carbamate-based NCEH inhibitor AX-13057 shows promising potency
Read More
AstraZeneca presents potent new MAPK 14 inhibitors
Read More
ASP-3026 shows antitumor activity in murine model of NSCLC
Read More
MorphoSys and ContraFect join to develop therapeutic antibodies for infectious diseases
Read More
Preclinical data suggest benefit of allopurinol in diabetes-related nephropathy
Read More
REP-9AC shows promise as a therapy for hepatitis B
Read More
Enanta prepares new HCV NS5A inhibitors
Read More
RegeneRx refocuses clinical development program
Read More
Apricus Biosciences seeks FDA orphan drug status for RayVa in systemic sclerosis
Read More
Access Pharmaceuticals enters agreement for RNAi therapeutic delivery technologies
Read More
Amunix and Biogen Idec enter research agreement for recombinant blood factors
Read More
Regulus and UCSD to seek new microRNA therapeutics for angiogenic diseases
Read More
U.S. Department of Defense awards grant to study ganaxolone in fragile X syndrome
Read More
InSite Vision files response regarding SPA for phase III blepharitis study
Read More
FDA receives reports of hepatosplenic T-cell lymphoma in patients on TNF inhibitors
Read More
Galapagos discontinues phase II trial of GLPG-0259 in rheumatoid arthritis
Read More
Axcan to acquire Mpex Pharmaceuticals
Read More
Takeda lauches Edarbi for the treatment of hypertension in the U.S.
Read More
GSK submits MAA in Europe for Tyverb with paclitaxel in metastatic breast cancer
Read More
Proteon begins enrollment in phase II study of PRT-201 in hemodialysis patients
Read More